PANK4 and glioblastoma: The prospect of PANK4 as a target for re‐sensitization to TMZ treatment was assessed across additional TMZ‐resistant GBM cells.[21, 22] These included drug‐resistant T98G and U251 cells (from now on referred to as T98GRes and U251Res respectively) that were established following continuous exposure of their parental counterparts to increasing TMZ concentrations,[21, 22] as well as the inherently TMZ‐resistant T98G cell line (from now on referred to as T98GPar).